A new study by Harvard Medical School investigators at Brigham and Women’s and Massachusetts General hospitals, in collaboration with colleagues at Boston Children’s Hospital, sheds new light on the role of somatic mutations in TLE — DNA alterations that occur after conception — and suggests the potential of using existing cancer therapies to treat TLE that is resistant to anti-seizure medications.
Epilepsy Agency of the Big Bend (EABB)
Serving the Big Bend
